Rotigotine is a non-ergotropic dopamine agonist used in the management of Parkinson’s disease and restless legs syndrome. It is administered transdermally via a patch, delivering continuous dopaminergic stimulation and improving motor and non-motor symptoms. The term refers to the chemical compound acting as a receptor agonist rather than a therapeutic class.
Full pronunciation guide
